Ledger.Open graph →
SEC Form D · filed March 20, 2020

Lyell Immunopharma, Inc

Offering
$493.0M
Sold
$493.0M
Exemption
Rule 506(b)
Industry
Pharmaceuticals
Location
SOUTH SAN FRANCISCO, CA
Type
—

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (22)

Nicholas Restifo · South San Francisco, CAExecHans Bishop · Seattle, WADirectorRobert Nelson · San Diego, CADirectorCatherine Friedman · St Paul, MNDirectorStephen Hill · South San Francisco, CAExecHeather Turner · South San Francisco, CAExecRichard Goold · San Francisco, CAExecMargo Roberts · Dallas, TXExecStan Riddell · South San Francisco, CAExecElizabeth Homans · South San Francisco, CAExecRichard Klausner · Mountain View, CAExec · Director · PromoterRobert Nelson · Carlsbad, CADirectorCatherine Friedman · South San Francisco, CADirectorStephen Hill · South San Francisco, CAExecHeather Turner · South San Francisco, CAExecRichard Goold · South San Francisco, CAExecMargo Roberts · South San Francisco, CAExecNicholas Restifo · South San Francisco, CAExecStan Riddell · South San Francisco, CAExecHans Bishop · Seattle, WADirectorElizabeth Homans · South San Francisco, CAExecRichard Klausner · Mountain View, CAExec · Director · Promoter

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗